Key Takeaways
- • AI companies captured 88.8% of U.S. venture deal value in 2025, up from 14.6% a decade earlier, concentrating institutional capital flows in a narrow subset of sectors and companies.
- • U.S. VC deal value reached $320 billion in 2025 (second-highest on record), but approximately 60% of all invested capital went to just 629 companies raising rounds of $100 million or more, leaving growth-stage non-AI companies materially underserved.
- • Growth-stage B2B SaaS and other non-AI companies now face longer fundraising processes, fewer competing term sheets, lower valuations, and weaker terms compared to 2022, even when demonstrating strong unit economics and revenue growth.
- • A typical Series B scenario illustrates the shift: a B2B SaaS company growing from $2 million to $5 million ARR that received five or six competing term sheets in 2022 now faces significantly reduced bidder competition as venture firms redeploy capital toward AI-native startups.
- • Founders cannot control capital allocation flows, but can position their companies strategically to access institutional capital in the current environment of concentrated venture investment.
Summary
The venture capital market entered 2026 facing a structural concentration unprecedented in recent history. According to PitchBook and NVCA's Venture Monitor Q1 report, AI companies accounted for 88.8% of U.S. venture deal value in 2025, a dramatic shift from 14.6% a decade earlier. While headline figures show the market remains robust—U.S. VC deal value reached $320 billion, the second-highest total on record—this aggregate strength masks a profound reallocation of capital away from non-AI growth-stage companies.
The concentration is acute by dollar volume. Crunchbase data reveals that close to 60% of all invested capital in 2025 went to just 629 companies raising rounds of $100 million or more. This leaves a substantial cohort of well-capitalized, profitable growth-stage companies competing for a drastically reduced pool of available institutional capital. The impact manifests directly in deal economics and fundraising timelines. A B2B SaaS company that raised a $10 million Series A in 2022 at eight times annual recurring revenue, having grown from $2 million to $5 million ARR, would have attracted five or six competing term sheets three years ago. Today, many venture firms have redeployed capital toward new AI-native startups, eliminating competitive tension and dramatically weakening the negotiating position of non-AI companies.
The valuation penalty is measurable and material. Non-AI growth-stage companies with strong fundamentals—consistent revenue growth, healthy unit economics, and institutional track records—now experience longer fundraising processes, fewer bidders, lower valuations, and inferior terms compared to the 2022–2024 period. These companies are not failing; they remain deserving of institutional capital by historical standards. Instead, they face a market where the allocation mechanism itself has fundamentally shifted. As Wayne Cantwell, Co-Founder and Managing Director of Decathlon Capital Partners, notes, founders cannot control where institutional capital flows. The strategic challenge lies in positioning companies to compete effectively within the new constraints of venture capital allocation, where AI dominance has created a two-tier funding environment.
The concentration is acute by dollar volume. Crunchbase data reveals that close to 60% of all invested capital in 2025 went to just 629 companies raising rounds of $100 million or more. This leaves a substantial cohort of well-capitalized, profitable growth-stage companies competing for a drastically reduced pool of available institutional capital. The impact manifests directly in deal economics and fundraising timelines. A B2B SaaS company that raised a $10 million Series A in 2022 at eight times annual recurring revenue, having grown from $2 million to $5 million ARR, would have attracted five or six competing term sheets three years ago. Today, many venture firms have redeployed capital toward new AI-native startups, eliminating competitive tension and dramatically weakening the negotiating position of non-AI companies.
The valuation penalty is measurable and material. Non-AI growth-stage companies with strong fundamentals—consistent revenue growth, healthy unit economics, and institutional track records—now experience longer fundraising processes, fewer bidders, lower valuations, and inferior terms compared to the 2022–2024 period. These companies are not failing; they remain deserving of institutional capital by historical standards. Instead, they face a market where the allocation mechanism itself has fundamentally shifted. As Wayne Cantwell, Co-Founder and Managing Director of Decathlon Capital Partners, notes, founders cannot control where institutional capital flows. The strategic challenge lies in positioning companies to compete effectively within the new constraints of venture capital allocation, where AI dominance has created a two-tier funding environment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.